ISB News

Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

ISB’s Dr. Lee Hood presented the PMWC Luminary Award to Dr. Anthony Fauci on Monday, and the two renowned scientists engaged in an interesting hour-long conversation. 

The Luminary Award was presented on behalf of Precision Medicine World Conference on the first day of PMWC COVID, a three-day virtual event. The award recognizes contributions of prominent figures who have accelerated personal medicine to the clinic.

Hood spoke with Fauci, director of the National Institute of Allergy and Infectious Disease, about a number of topics, including the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19 and the technology’s promise for creating effective vaccines for other diseases (including some cancers), lessons learned from the COVID-19 pandemic, and more. 

“We should have a vaccine, as well as universally applicable antivirals, that we could use for the next outbreak,” Fauci said. “I would be really disappointed if when this is over we don’t put together a commission and codify what we need to do as opposed to saying ‘well, we got through that, now let’s worry about the next problem’.”

You can watch the conversation here or by playing the video above.

Recent Articles

  • Microbiome and weight loss

    Can You Lose Weight? Ask Your Microbiome

    The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome. These new findings open the door to diagnostic tests that can identify people likely to lose weight with healthy lifestyle changes and those who might need more drastic interventions.

  • Drs. Jim Heath, Yapeng Su and Jihoon Lee

    Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival

    Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.

  • 2021 ISB Microbiome Series

    2021 ISB Virtual Microbiome Series Announced

    Our multi-day microbiome-themed virtual course and symposium is back by popular demand! ISB is hosting a two-day course on October 13 & 14, followed by a symposium on October 15. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.